300171.SZ
300171.SZ
CNE100000ZP0
TOFFLON
Loading chart...

Company Profile

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. The company offers technological research, including cell technology, complex preparation, injection, and OSD laboratory; instruments comprising cell therapy and nucleic acid drugs instruments, laboratory facilities, and table reactor; single use technology that include bioreactors, liquid distribution systems, sterile bags, process chromatography, membrane filtration systems, and others; and cryopreservation system for seeds and biological samples, as well as freeze-thaw system of biological stock solutions. It also provides culture medium, such as cell and gene therapy, biomacromolecule drugs, tobitec feeding medium, and other series; bioreactors, fermentation systems, cell factory, perfusion, and complementary systems; preparation systems, including bio-process vessel and piping, common solutions preparation, and complex injectable formulation systems; and separation and purification systems comprising disc centrifuge, membrane filtration, chromatography system and columns, alkali lysis, slurry tank, and filters. In addition, the company offers resins, API, cleaning and sterilization, filling line, and OSD products and services. Further, it provides freeze-drying systems that include laboratory, production, and special application freeze-drying products, as well as loading and unloading system; packaging systems, such as packaging solutions, cartoner machine, top-load cartoner machines, blister machine, solid bottling equipment, labelling machine, and case packer with palletizer machines; isolator and inspection systems; and engineering services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. Tofflon Science and Technology Group Co., Ltd. was founded in 1993 and is headquartered in Shanghai, China.

Related stocks

300573.SZ
300573.SZ • China
XQYY
35.55 CNY
1.89B USD 1Y -23.3%
1066.HK
1066.HK • China
WEIGAO GROUP
3.31 HKD
1.89B USD 1Y -45.4%
688029.SS
688029.SS • China
MICRO-TECH (NANJING) CO LTD
83.3 CNY
2.34B USD 1Y -15.2%
2276.HK
2276.HK • China
CONANT OPTICAL
35.6 HKD
2.19B USD 1Y -13.4%
688289.SS
688289.SS • China
SANSURE BIOTECH INC
17.02 CNY
1.46B USD 1Y -20.3%
688050.SS
688050.SS • China
EYEBRIGHT MEDICAL TECHNOLOGY (B
39.16 CNY
1.13B USD 1Y -46.9%
300595.SZ
300595.SZ • China
AUTEK
10.31 CNY
1.38B USD 1Y -39.9%
603301.SS
603301.SS • China
ZHENDE MEDICAL CO LTD
81 CNY
3.2B USD 1Y +57.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
44.0% p.a.
Max Drawdown (5Y)
-82.6%
Sharpe Ratio (5Y)
-0.42
Beta Factor
0.28
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 46.9 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -84.6% in the extended horizon.
ende